India Proposes Formula for Clinical Trial Death Compensation

Drug Industry Daily
Drug companies conducting clinical trials in India would be required to pay significant compensation for deaths of some subjects during a study, under a proposed formula released last week that lays out the conditions and amounts of payment.

To View This Article:


Subscribe To Drug Industry Daily